Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

M.I. Kester; C.E. Teunissen; D.L. Crimmins; E.M. Herries; J.H. Ladenson; P. Scheltens; W.M. van der Flier; J.C. Morris; D.M. Holtzman; A.M. Fagan

doi:10.1001/jamaneurol.2015.1867

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

M.I. Kester, C.E. Teunissen, D.L. Crimmins, E.M. Herries, J.H. Ladenson, P. Scheltens, W.M. van der Flier, J.C. Morris, D.M. Holtzman, A.M. Fagan

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1275-1280
Journal	JAMA Neurology
Volume	72
Issue number	11
DOIs	https://doi.org/10.1001/jamaneurol.2015.1867
Publication status	Published - 2015

Access to Document

10.1001/jamaneurol.2015.1867

Cite this

@article{bfbf892aad1a4544ace63c68100f4571,

title = "Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease",

author = "M.I. Kester and C.E. Teunissen and D.L. Crimmins and E.M. Herries and J.H. Ladenson and P. Scheltens and {van der Flier}, W.M. and J.C. Morris and D.M. Holtzman and A.M. Fagan",

year = "2015",

doi = "10.1001/jamaneurol.2015.1867",

language = "Undefined/Unknown",

volume = "72",

pages = "1275--1280",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

AU - Kester, M.I.

AU - Teunissen, C.E.

AU - Crimmins, D.L.

AU - Herries, E.M.

AU - Ladenson, J.H.

AU - Scheltens, P.

AU - van der Flier, W.M.

AU - Morris, J.C.

AU - Holtzman, D.M.

AU - Fagan, A.M.

PY - 2015

Y1 - 2015

U2 - 10.1001/jamaneurol.2015.1867

DO - 10.1001/jamaneurol.2015.1867

M3 - Article

C2 - 26366630

VL - 72

SP - 1275

EP - 1280

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 11

ER -